Sign In
Home
Lenalidomide - Lenalidomide capsule
Get your patient on
Lenalidomide - Lenalidomide capsule
(Lenalidomide)
oral pill - 2.5 mg cap
Check coverage
See the specific documentation and step therapies required.
Check coverage
Medication interactions
See all drug-to-drug interactions for this medication.
Check interactions
Prescribing info
PubMed™ news
Lenalidomide - Lenalidomide capsule prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Lenalidomide - Lenalidomide capsule PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Lenalidomide - Lenalidomide capsule
,
view all articles on PubMed™
Journal Article • 2026 Jun
Response to comment on "Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study".
Journal Article • 2026 Jun
A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma.
Journal Article • 2026 Jun
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.
Journal Article • 2026 May
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
Journal Article • 2026 May
Maintenance treatment and survival in patients with newly diagnosed diffuse large B cell lymphoma in the immunochemotherapy era: a systematic review and network meta-analysis.
Show the latest PubMed™ articles for Lenalidomide - Lenalidomide capsule
I certify that I'm a U.S. healthcare provider
